These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24508816)

  • 21. A fluorescent probe for imaging p53-MDM2 protein-protein interaction.
    Liu Z; Miao Z; Li J; Fang K; Zhuang C; Du L; Sheng C; Li M
    Chem Biol Drug Des; 2015 Apr; 85(4):411-7. PubMed ID: 25226874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of novel dihydroimidazothiazole derivatives as p53-MDM2 protein-protein interaction inhibitors: synthesis, biological evaluation and structure-activity relationships.
    Miyazaki M; Kawato H; Naito H; Ikeda M; Miyazaki M; Kitagawa M; Seki T; Fukutake S; Aonuma M; Soga T
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6338-42. PubMed ID: 22995624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Basic detection methods for protein-protein interaction inhibitors].
    Kato M; Utata R; Tsuganezawa K; Tanaka A
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1557-62. PubMed ID: 21089588
    [No Abstract]   [Full Text] [Related]  

  • 24. A yeast two-hybrid system for the screening and characterization of small-molecule inhibitors of protein-protein interactions identifies a novel putative Mdm2-binding site in p53.
    Wong JH; Alfatah M; Sin MF; Sim HM; Verma CS; Lane DP; Arumugam P
    BMC Biol; 2017 Nov; 15(1):108. PubMed ID: 29121928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatment.
    Zhao Y; Aguilar A; Bernard D; Wang S
    J Med Chem; 2015 Feb; 58(3):1038-52. PubMed ID: 25396320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular interaction fields and 3D-QSAR studies of p53-MDM2 inhibitors suggest additional features of ligand-target interaction.
    Dezi C; Carotti A; Magnani M; Baroni M; Padova A; Cruciani G; Macchiarulo A; Pellicciari R
    J Chem Inf Model; 2010 Aug; 50(8):1451-65. PubMed ID: 20726601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small-molecule inhibitors of protein-protein interactions: how to mimic a protein partner.
    Fry DC
    Curr Pharm Des; 2012; 18(30):4679-84. PubMed ID: 22650256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The fluorescent two-hybrid assay to screen for protein-protein interaction inhibitors in live cells: targeting the interaction of p53 with Mdm2 and Mdm4.
    Yurlova L; Derks M; Buchfellner A; Hickson I; Janssen M; Morrison D; Stansfield I; Brown CJ; Ghadessy FJ; Lane DP; Rothbauer U; Zolghadr K; Krausz E
    J Biomol Screen; 2014 Apr; 19(4):516-25. PubMed ID: 24476585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small molecular weight protein-protein interaction antagonists: an insurmountable challenge?
    Dömling A
    Curr Opin Chem Biol; 2008 Jun; 12(3):281-91. PubMed ID: 18501203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An antibody-free strategy for screening putative HDM2 inhibitors using crude bacterial lysates expressing GST-HDM2 recombinant protein.
    Costa B; Grillone AF; Salvetti A; Rocchiccioli S; Iacopetti P; Daniele S; Da Pozzo E; Campiglia P; Novellino E; Martini C; Rossi L
    Drug Test Anal; 2013 Jul; 5(7):596-601. PubMed ID: 23733564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ensemble-based virtual screening reveals dual-inhibitors for the p53-MDM2/MDMX interactions.
    Barakat K; Mane J; Friesen D; Tuszynski J
    J Mol Graph Model; 2010 Feb; 28(6):555-68. PubMed ID: 20056466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous measurement of p53:Mdm2 and p53:Mdm4 protein-protein interactions in whole cells using fluorescence labelled foci.
    Frosi Y; Inoue K; Ramlan SR; Lane DP; Watanabe T; Brown CJ
    Sci Rep; 2019 Nov; 9(1):17933. PubMed ID: 31784573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioorthogonal Probes for the Study of MDM2-p53 Inhibitors in Cells and Development of High-Content Screening Assays for Drug Discovery.
    D'Alessandro PL; Buschmann N; Kaufmann M; Furet P; Baysang F; Brunner R; Marzinzik A; Vorherr T; Stachyra TM; Ottl J; Lizos DE; Cobos-Correa A
    Angew Chem Int Ed Engl; 2016 Dec; 55(52):16026-16030. PubMed ID: 27874234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P53 mdm2 inhibitors.
    Khoury K; Dömling A
    Curr Pharm Des; 2012; 18(30):4668-78. PubMed ID: 22650254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small molecule agents targeting the p53-MDM2 pathway for cancer therapy.
    Wang W; Hu Y
    Med Res Rev; 2012 Nov; 32(6):1159-96. PubMed ID: 23059763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of small-molecule inhibitors of the human S100B-p53 interaction and evaluation of their activity in human melanoma cells.
    Yoshimura C; Miyafusa T; Tsumoto K
    Bioorg Med Chem; 2013 Mar; 21(5):1109-15. PubMed ID: 23375094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of libraries targeting protein-protein interfaces.
    Fry D; Huang KS; Di Lello P; Mohr P; Müller K; So SS; Harada T; Stahl M; Vu B; Mauser H
    ChemMedChem; 2013 May; 8(5):726-32. PubMed ID: 23436619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simple cell-based HTS assay system to screen for inhibitors of p53-Hdm2 protein-protein interactions.
    Lundholt BK; Heydorn A; Bjørn SP; Praestegaard M
    Assay Drug Dev Technol; 2006 Dec; 4(6):679-88. PubMed ID: 17199506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective screening strategy using ensembled pharmacophore models combined with cascade docking: application to p53-MDM2 interaction inhibitors.
    Xue X; Wei JL; Xu LL; Xi MY; Xu XL; Liu F; Guo XK; Wang L; Zhang XJ; Zhang MY; Lu MC; Sun HP; You QD
    J Chem Inf Model; 2013 Oct; 53(10):2715-29. PubMed ID: 24050442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of a new small-molecule inhibitor of p53-MDM2 interaction using a yeast-based approach.
    Leão M; Pereira C; Bisio A; Ciribilli Y; Paiva AM; Machado N; Palmeira A; Fernandes MX; Sousa E; Pinto M; Inga A; Saraiva L
    Biochem Pharmacol; 2013 May; 85(9):1234-45. PubMed ID: 23428467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.